| Prev Close | 3.65 |
| Open | 3.60 |
| Day Low/High | 3.60 / 3.75 |
| 52 Wk Low/High | 2.48 / 21.00 |
| Volume | 19.65K |
| Avg Volume | 31.30K |
| Exchange | NASDAQ |
| Shares Outstanding | 23.81M |
| Market Cap | 88.08M |
| EPS | -2.40 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
ATyr Pharma Announces Issuance Of US Patent That Extends Patent Protection Of Physiocrines Derived From 20 Out Of 20 Human TRNA Synthetases
- Estate Covers over 175 Patents for Physiocrine Biology, a New Class of Potential Targets and Therapeutics -
ATyr Pharma Reports Promising Signals Of Clinical Activity In Multiple Rare Genetically Distinct Myopathies With Resolaris™ In Exploratory Trials
- Improved Muscle Strength Observed in 50% to 78% of Patients in Two Rare Genetically Distinct Myopathies -
ATyr Pharma Receives FDA Fast Track Designation For Resolaris™ To Treat Facioscapulohumeral Muscular Dystrophy (FSHD)
-- First Reported Fast Track Designation for a FSHD Treatment --
7 Stocks Under $10 Making Big Moves Higher
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
These 5 Stocks Are Breaking Out
Here's a technical look at how to trade five stocks that are within range of triggering big breakouts.
5 Stocks With Big Insider Buying
Insiders at these companies have been scooping up shares of their own stock lately.
Here’s A Reason aTyr Pharma (LIFE) Stock is Rising Today
Shares of aTyr Pharma (LIFE) are climbing late Tuesday afternoon as BMO Capital began coverage of the stock with a ‘market perform’ rating and $8 price target.
5 Stocks Poised for Breakouts
These stocks look ready to break out and trade higher from current levels.
